Bio-Rad Introduces the IH-500, a Fully Automated Random Access System for Blood Typing and Screening
Designed for Small and Medium-Size Transfusion Medicine Laboratories
(firmenpresse) - HERCULES, CA -- (Marketwired) -- 08/03/15 -- Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIO.B), today announced the launch of the -500, a fully automated random access system for blood typing and screening, providing small and medium-size transfusion medicine laboratories fast and reliable results in a 24/7 environment. The -500 system is available in Europe, Asia, Africa, Australia, and Latin America.
The -500 system can handle the entire range of Bio-Rad ID gel cards for ABO blood grouping, reverse testing, phenotype, Rh-subgroups, antibody screening, antibody identification, single antigen testing, direct AHG testing (DAT), and crossmatch. The system incorporates a 6-axis robot transport arm offering a high level of automation and minimizing user operations. The -500 system also offers enhanced safety checks, extended reagent storage, and dynamic sample work flow management that provides additional efficiencies.
The seamless integration of -500 with -Com (software for data management and results interpretation) and -Web (software for remote result management) significantly improves the workflow from small labs to large lab networks.
"We are pleased to introduce the -500 automated blood typing system, a new and advanced generation of technology that has the flexibility to offer a cost-effective solution for both small and mid-volume labs," said John Hertia, Bio-Rad Executive Vice President, President, Clinical Diagnostics Group. "The system reduces user operations and provides many new efficiencies to our customers."
Can operate as stand-alone system or as a bench-top analyzer, offering a high level of flexibility towards customized solutions
As part of the total system solution, the -500 can be connected with other Bio-Rad instruments to create one seamlessly integrated lab system
Incorporates proven industrial technology to provide a robust and reliable system
Offers patient safety through established ID gel card technology as well as photo quality/clear results
For further information about the -500 fully automated system for blood testing and screening, please visit .
Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIO.B) develops, manufactures, and markets a broad range of innovative products and solutions for the life science research and clinical diagnostic markets. The company is renowned for its commitment to quality and customer service among university and research institutions, hospitals, public health and commercial laboratories, as well as the biotechnology, pharmaceutical, and food safety industries. Founded in 1952, Bio-Rad is based in Hercules, California, and serves more than 100,000 research and healthcare industry customers through its global network of operations. The company employs more than 7,600 people worldwide and had revenues exceeding $2.1 billion in 2014. For more information, please visit .
Bio-Rad Laboratories, Inc.
Tina Cuccia
Corporate Communications
510-724-7000
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 03.08.2015 - 12:30 Uhr
Sprache: Deutsch
News-ID 411015
Anzahl Zeichen: 0
contact information:
Town:
HERCULES, CA
Kategorie:
Healthcare
Diese Pressemitteilung wurde bisher 341 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Bio-Rad Introduces the IH-500, a Fully Automated Random Access System for Blood Typing and Screening"
steht unter der journalistisch-redaktionellen Verantwortung von
Bio-Rad Laboratories (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
